Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
935
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$31.5B
-
Value change
-
-$463M
-
Put/Call ratio
-
0.91
-
Number of buys
-
395
-
Number of sells
-
-442
-
Price
-
$257.01
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2023
1,119 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q3 2023.
BIOGEN INC. - Common Stock (BIIB) has 935 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 147M outstanding shares and own 83.23% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16M shares), BlackRock Inc. (14M shares), VANGUARD GROUP INC (12.2M shares), STATE STREET CORP (6.87M shares), WELLINGTON MANAGEMENT GROUP LLP (5.37M shares), JPMORGAN CHASE & CO (4.99M shares), T. Rowe Price Investment Management, Inc. (4.75M shares), GEODE CAPITAL MANAGEMENT, LLC (3.24M shares), Clearbridge Investments, LLC (1.82M shares), and NORTHERN TRUST CORP (1.64M shares).
This table shows the top 935 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.